Ahmedabad
FDA slaps import ban on Claris Life Sciences
November 16, 2010Manufacturing and Production Ahmedabad, Claris Life Sciences, FDA, GMP, GMP violations, Good Manufacturing Practice, Ranbaxy Pharmaceuticals, manufacturing compliance
Indian drugmaker Claris Life Sciences has been prohibited from importing products into the US after manufacturing quality problems emerged at …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
